Please login or register first to view this content.
Musculoskeletal Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Xeomin Approved as First-Line Treatment for Blepharospasm
Fluoroquinolone Use Linked to Increased Peripheral Neuropathy Risk
Oral Contraceptive Pill May Protect Against ACL Tears
Nusinersen Promising for Later-Onset Spinal Muscular Atrophy
Risks, Benefits of Long-Term Drug Therapy for Osteoporosis Reviewed
Ixekizumab Effective in Phase 3 Non-Radiographic Axial Spondyloarthritis Trial
Statins Safe, Effective in Rheumatoid Arthritis Patients
Mixed Results for Tanezumab in Phase 3 Osteoarthritis Trial
Patients Develop Inflammatory Arthritis Following Clopidogrel Initiation
Pamrevlumab Gets Orphan Drug Designation for Duchenne Muscular Dystrophy
Turmeric Supplementation Linked to Patient’s Iron Deficiency Anemia
Chloroprocaine Offers Adequate Anesthesia for Knee Arthroscopy
Evenity Approved to Treat Osteoporosis in Postmenopausal Women at High Risk for Fracture
Filgotinib Meets Primary Endpoints in Two Rheumatoid Arthritis Studies
FDA Approves First Treatment for Non-Radiographic Axial Spondyloarthritis
Treatments for Preventing Fracture in Postmenopausal Women Compared
Recommendations Issued for Treating Osteoporosis
Clinical Outcomes Compared With Generics, Brand-Name Drugs for Chronic Conditions
